Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 790 of 1,261

  1. US 8846770

    Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders

    The Regents of the University of California · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  2. US 8846752

    Isoflavone fatty acid ester derivatives, preparation method and pharmaceutical uses thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  3. US 8846101

    Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions

    TAKEDA NYCOMED AS · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  4. US 8846389

    AAV4 vector and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  5. US 8846753

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  6. US 8846635

    Method for inducing hepatocyte proliferation and uses thereof

    CAN-FITE BIOPHARMA LTD. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  7. US 8846600

    Carboxamide compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  8. US 8846697

    Purine analogs

    The Regents of the University of California · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  9. US 8846629

    Id-1 and Id-2 genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma

    The Regents of the University of California · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  10. US 8846648

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  11. US 8846627

    Method for treatment of malaria

    East China University of Science and Technology · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  12. US 8846638

    Macrocyclic nucleoside phosphoramidate derivatives

    Enanta Pharmaceuticals, Inc. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  13. US 8846918

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  14. US 8846713

    Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  15. US 8846055

    Virulence determinant within the E2 structural glycoprotein of classical swine fever virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  16. US 8846102

    Non-viral compositions and methods for transfecting gut cells in vivo

    ENGENE, INC. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  17. US 8846649

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  18. US 8846605

    Formulations and methods of use for alpha connexin C-terminal (ACT) peptides

    FIRSTRING RESEARCH, INC. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  19. US 8846643

    Phosphonates with reduced toxicity for treatment of viral infections

    The Regents of the University of California · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  20. US 8841323

    1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors

    Addex Pharma, S.A. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  21. US 8841258

    Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation

    The Regents of the University of California · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  22. US 8841450

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  23. US 8841483

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  24. US 8841333

    Methods for treating nephrolithiasis

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.